Company news
Sareum Holdings plc news in 2022
Sareum Holdings plc's news releases, calls and decks from 2022, newest first.
Director/PDMR Shareholding
December 29, 2022
AGM Statement
December 16, 2022
Sareum notes publication of SRA737 clinical data
November 21, 2022
Second Price Monitoring Extn
November 9, 2022
Price Monitoring Extension
November 9, 2022
Update on SDC-1801 CTA Application
November 8, 2022
Final Results for the Year Ended 30 June 2022
October 24, 2022
Update on SAR737
October 12, 2022
Sareum notes FDA approval of first TYK2 Inhibitor
September 12, 2022
CTA application to MHRA and Corporate Update
July 28, 2022
Sareum notes GSK's completed acquisition of Sierra
July 4, 2022
Sareum to Present at BioTrinity 2022 Conference
April 26, 2022
Sareum notes acquisition of Sierra Oncology by GSK
April 13, 2022
European Patent Granted for Sareum's SDC-1802
April 11, 2022
SDC-1801: Preclinical Toxicology Report Received
March 16, 2022
Results of EGM
February 28, 2022
Half-year Report
February 21, 2022
Publication of Circular; Notice of General Meeting
February 4, 2022
Correction - Issue of Warrants
January 28, 2022
Issue of Warrants
January 28, 2022
Sareum to Participate in Edison Open House Event
January 25, 2022
Calls in 2022
Decks in 2022
- Investor Presentation (August 2022)
Investor deck · 15 slides · August 2022
- H1 2022 Earnings Presentation
Earnings · 13 slides · Feb 28, 2022